Decentralized access Leverage No Resistance’s network of 30+ diverse clinical sites across urgent care, STI clinics, and specialty practices to offer sponsors broad real-world access for diagnostics and early cancer detection studies.

Early detection focus Target opportunities in GI, OB/GYN, urology, and oncology workflows to evaluate IVD, LDT, POC, and OTC tests in real-world screening and diagnostic pathways, aligning with cancer surveillance and early detection needs.

Rapid enrollment Position the network’s high-volume clinical environments as a strength for rapid patient enrollment and representative data collection, reducing timelines for study milestones.

Regulatory relevance Emphasize decentralized real-world execution that improves generalizability and regulatory relevance, appealing to sponsors seeking data that mirrors actual clinical use.

Tech-enabled scale Highlight the scalable tech stack and cloud-based operations (AWS, Cloudflare, WordPress, Microsoft 365) as a foundation for secure study management, rapid site onboarding, and seamless sponsor collaboration.